Literature DB >> 26741742

An Empirical Investigation of a Biopsychosocial Model of Pain in Multiple Sclerosis.

Melissa A Day1, Dawn M Ehde, L Charles Ward, Narineh Hartoonian, Kevin N Alschuler, Aaron P Turner, George H Kraft, Mark P Jensen.   

Abstract

OBJECTIVES: Pain is a significant problem for many individuals with multiple sclerosis (MS). Pain is often associated with other MS symptoms (eg, physical, sensorimotor, cognitive declines), and both pain and MS symptoms are hypothesized to contribute to psychosocial problems (eg, depression), other symptoms (eg, fatigue, sleep disturbance), and functional impairments (eg, pain interference). On the basis of a biopsychosocial model, we sought to: (1) examine the associations between pain, MS symptoms, depression, psychosocial, and functional variables and (2) identify possible risk and protective factors associated with pain in MS.
MATERIALS AND METHODS: A cross-sectional survey was completed by 424 individuals with MS. Pain, MS symptoms, demographics, MS diagnostic factors, and psychosocial and functional variables were assessed. Data were analyzed by structural equation models.
RESULTS: Participants were predominantly white (92%), middle-aged (mean=50.7 y), and female (80%). Results indicated that pain severity and depression accounted for >50% of the variance in pain interference. Although pain contributed minimally to fatigue and sleep quality, depression and MS symptoms predicted 49% of the variance in fatigue, and depression was largely responsible for the 40% of predicted variance in sleep quality. Identified risk factors for pain were low educational attainment and lack of a committed/marital relationship, even while controlling for diagnostic and other key demographic variables. DISCUSSION: Results highlight the importance of targeting interventions toward improving coping skills and social support within the context of pain and MS. Research is needed to determine whether effectively targeting depression in MS results in improvements of other critical psychosocial and physical functioning domains.

Entities:  

Mesh:

Year:  2016        PMID: 26741742     DOI: 10.1097/AJP.0000000000000240

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  8 in total

1.  Cognitive and affective mechanisms of pain and fatigue in multiple sclerosis.

Authors:  Anne Arewasikporn; Aaron P Turner; Kevin N Alschuler; Abbey J Hughes; Dawn M Ehde
Journal:  Health Psychol       Date:  2018-04-19       Impact factor: 4.267

Review 2.  Multiple Sclerosis-Related Pain Syndromes: An Imaging Update.

Authors:  Amir Mazhari
Journal:  Curr Pain Headache Rep       Date:  2016-12

3.  Positive factors, pain, and function in adults with multiple sclerosis.

Authors:  Anne Arewasikporn; Dawn M Ehde; Kevin N Alschuler; Aaron P Turner; Mark P Jensen
Journal:  Rehabil Psychol       Date:  2018-10-08

4.  The Problem of Pain in Systemic Lupus Erythematosus: An Explication of the Role of Biopsychosocial Mechanisms.

Authors:  Titilola Falasinnu; Cristina Drenkard; Gaobin Bao; Sean Mackey; S Sam Lim
Journal:  J Rheumatol       Date:  2020-12-01       Impact factor: 5.346

5.  Is There an Association Between Social Support and Pain Among Individuals Living With Multiple Sclerosis?

Authors:  Khrisha B Alphonsus; Carl D'Arcy
Journal:  J Evid Based Integr Med       Date:  2021 Jan-Dec

6.  A scoping review to identify and map the multidimensional domains of pain in adults with advanced liver disease.

Authors:  Franklin F Gorospe; Laura Istanboulian; Martine Puts; David Wong; Elizabeth Lee; Craig M Dale
Journal:  Can J Pain       Date:  2020-09-15

7.  Overview: A Framework for the Discussion of Sleep in Multiple Sclerosis.

Authors:  Tiffany J Braley
Journal:  Curr Sleep Med Rep       Date:  2017-10-28

8.  THE EFFECT OF EDUCATIONAL INTERVENTION ON KNOWLEDGE AND SELF-EFFICACY FOR PAIN CONTROL IN PATIENTS WITH MULTIPLE SCLEROSIS.

Authors:  Seyde Shahrbanoo Daniali; Hossein Shahnazi; Samira Kazemi; Elnaz Marzbani
Journal:  Mater Sociomed       Date:  2016-07-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.